MDxHealth SA Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
MDxHealth SA income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue90.0570.1937.0522.2418.4611.7928.40
Cost of Revenue34.9126.2617.84-11.6810.4211.9311.65
Gross Profit55.1443.9319.2210.568.04-0.1416.75
Operating Expenses
Research & Development10.555.305.456.674.279.004.28
Selling, General & Administrative63.7850.9749.0134.0730.7410.1015.42
Operating Expenses79.8670.8057.7140.7434.8943.0348.84
Operating Income-24.72-26.87-38.49-30.17-26.85-43.17-32.10
Other Income/Expense
Interest Income1.081.090.130.010.000.010.02
Interest Expense-7.635.58-2.64-1.88-1.350.320.08
Other Income/Expense0.62-10.55-0.19-1.15-0.190.000.00
Income
Income Before Tax-37.69-43.10-44.04-29.00-28.66-43.68-32.49
Income Tax Expense0.380.000.000.000.00-0.58-0.04
Net Income-38.07-43.10-44.04-29.00-28.66-43.10-32.45
Net Income - Continuous Operations-38.07-43.10-44.04-29.000.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-18.96-17.90-33.58-26.20-24.29-39.94-29.47
EBIT-24.72-24.76-38.49-29.23-26.85-43.36-32.41
Depreciation & Amortization5.776.554.91-0.882.562.141.67
Earnings Per Share
Basic EPS-1.00-2.00-3.00--3.00-1.00-1.00
Diluted EPS-1.00-2.00-3.00--3.00-1.00-1.00
Basic Shares Outstanding32.8625.9115.872.208.3262.5857.61
Diluted Shares Outstanding32.8625.9115.87120.848.3262.5857.61